VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress
Published . Updated .
VERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its oncology pipeline and implementing industrial
Directly affected
Indirectly affected
- XOM Exxon Mobil+7.9%
Oil producers earn more when crude prices rise
- CVX Chevron+6.6%
Oil producers earn more when crude prices rise
- OXY Occidental Petroleum+1.5%
Oil producers earn more when crude prices rise
- COP ConocoPhillips+7.3%
Oil producers earn more when crude prices rise
- XLI Industrial Select Sector SPDR-1.0%
A fund of industrial companies
- CAT Caterpillar-8.0%
A large machinery maker
- VLO Valero+14.1%
Refiners' profits move with crude and fuel prices
- MPC Marathon Petroleum+10.2%
Refiners' profits move with crude and fuel prices
- XOP SPDR S&P Oil & Gas Exploration
A fund of oil and gas producers
- XLE Energy Select Sector SPDR
A fund of energy companies
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| NDAQ | +0.37% | -2.09% | base | -0.81% | +0.90% | +2.37% | +9.94% |
| TDAY | -1.43% | +2.58% | base | -0.14% | +0.36% | -0.86% | +0.86% |
| XOM | -3.82% | -1.14% | base | -0.44% | -0.63% | -0.52% | -0.46% |
| CVX | -4.43% | -1.29% | base | -0.22% | +0.30% | +0.79% | +0.71% |
| OXY | -2.02% | -1.55% | base | +0.54% | +0.87% | +0.50% | +0.16% |
| COP | -6.11% | -2.85% | base | -0.87% | -0.39% | -0.56% | -0.57% |
| XLI | +0.82% | -0.40% | base | -0.61% | -0.54% | +0.33% | -0.58% |
| CAT | +9.40% | +2.40% | base | -0.74% | -0.70% | +1.28% | -3.73% |
| VLO | -1.91% | +3.42% | base | -2.58% | -2.44% | -1.81% | -4.14% |
| MPC | -3.92% | +1.38% | base | -0.80% | -0.72% | -1.91% | -3.94% |
| XOP | -3.05% | -1.29% | base | -0.48% | -0.17% | -0.71% | -1.78% |
| XLE | -3.23% | -0.90% | base | -0.64% | -0.41% | -0.12% | -0.96% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress USA Today
Source: USA Today
Energy
| Company | When | Move | Status |
|---|---|---|---|
| CAT | that day | -0.74% | final price |
| CAT | the next day | -0.70% | final price |
| CAT | two days later | +1.28% | final price |
| CAT | three days later | -3.73% | final price |
| CAT | three days earlier | +2.40% | final price |
| CAT | five days earlier | +9.40% | final price |
| COP | that day | -0.87% | final price |
| COP | the next day | -0.39% | final price |
| COP | two days later | -0.56% | final price |
| COP | three days later | -0.57% | final price |
| COP | three days earlier | -2.85% | final price |
| COP | five days earlier | -6.11% | final price |
| CVX | that day | -0.22% | final price |
| CVX | the next day | +0.30% | final price |
| CVX | two days later | +0.79% | final price |
| CVX | three days later | +0.71% | final price |
| CVX | three days earlier | -1.29% | final price |
| CVX | five days earlier | -4.43% | final price |
| MPC | that day | -0.80% | final price |
| MPC | the next day | -0.72% | final price |
| MPC | two days later | -1.91% | final price |
| MPC | three days later | -3.94% | final price |
| MPC | three days earlier | +1.38% | final price |
| MPC | five days earlier | -3.92% | final price |
| NDAQ | that day | -0.81% | final price |
| NDAQ | the next day | +0.90% | final price |
| NDAQ | two days later | +2.37% | final price |
| NDAQ | three days later | +9.94% | final price |
| NDAQ | three days earlier | -2.09% | final price |
| NDAQ | five days earlier | +0.37% | final price |
| OXY | that day | +0.54% | final price |
| OXY | the next day | +0.87% | final price |
| OXY | two days later | +0.50% | final price |
| OXY | three days later | +0.16% | final price |
| OXY | three days earlier | -1.55% | final price |
| OXY | five days earlier | -2.02% | final price |
| TDAY | that day | -0.14% | final price |
| TDAY | the next day | +0.36% | final price |
| TDAY | two days later | -0.86% | final price |
| TDAY | three days later | +0.86% | final price |
| TDAY | three days earlier | +2.58% | final price |
| TDAY | five days earlier | -1.43% | final price |
| VLO | that day | -2.58% | final price |
| VLO | the next day | -2.44% | final price |
| VLO | two days later | -1.81% | final price |
| VLO | three days later | -4.14% | final price |
| VLO | three days earlier | +3.42% | final price |
| VLO | five days earlier | -1.91% | final price |
| XLE | that day | -0.64% | final price |
| XLE | the next day | -0.41% | final price |
| XLE | two days later | -0.12% | final price |
| XLE | three days later | -0.96% | final price |
| XLE | three days earlier | -0.90% | final price |
| XLE | five days earlier | -3.23% | final price |
| XLI | that day | -0.61% | final price |
| XLI | the next day | -0.54% | final price |
| XLI | two days later | +0.33% | final price |
| XLI | three days later | -0.58% | final price |
| XLI | three days earlier | -0.40% | final price |
| XLI | five days earlier | +0.82% | final price |
| XOM | that day | -0.44% | final price |
| XOM | the next day | -0.63% | final price |
| XOM | two days later | -0.52% | final price |
| XOM | three days later | -0.46% | final price |
| XOM | three days earlier | -1.14% | final price |
| XOM | five days earlier | -3.82% | final price |
| XOP | that day | -0.48% | final price |
| XOP | the next day | -0.17% | final price |
| XOP | two days later | -0.71% | final price |
| XOP | three days later | -1.78% | final price |
| XOP | three days earlier | -1.29% | final price |
| XOP | five days earlier | -3.05% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. April McClain Delaney sold Nasdaq (NDAQ) (held by a dependent child), worth $100,001 - $250,000 on 25 Aug 2026. That is 53 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Kevin Hern sold ExxonMobil Holdings (XOM) (jointly held), worth $100,001 - $250,000 on 31 Aug 2026. That is 47 days before publication. Filed 25 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, bought ExxonMobil Holdings (XOM), worth $250,001 - $500,000 on 31 Jul 2026. That is 78 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Kevin Hern sold Chevron (CVX) (jointly held), worth $15,001 - $50,000 on 23 Sep 2026. That is 24 days before publication. Filed 13 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Chevron (CVX), worth $1,001 - $15,000 on 2 Sep 2026. That is 45 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, sold Chevron (CVX), worth $15,001 - $50,000 on 31 Jul 2026. That is 78 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Michael T. McCaul sold Conocophillips (COP) (held by a spouse), worth $1,001 - $15,000 on 26 Aug 2026. That is 52 days before publication. Filed 14 Oct 2026. View the filing.
- Rep. Michael T. McCaul sold Conocophillips (COP) (held by a spouse), worth $1,001 - $15,000 on 24 Aug 2026. That is 54 days before publication. Filed 14 Oct 2026. View the filing.
- Rep. Michael T. McCaul sold Conocophillips (COP) (held by a spouse), worth $1,001 - $15,000 on 14 Aug 2026. That is 64 days before publication. Filed 14 Oct 2026. View the filing.
- Rep. Lisa McClain bought Caterpillar (CAT) (held by a spouse), worth $1,001 - $15,000 on 28 Sep 2026. That is 19 days before publication. Filed 12 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Caterpillar (CAT), worth $50,001 - $100,000 on 31 Jul 2026. That is 78 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Caterpillar (CAT) (held by a dependent child), worth $1,001 - $15,000 on 27 Jul 2026. That is 82 days before publication. Filed 7 Aug 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid the energy case looks
12 out of 100
“VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress” scores 12 out of 100. The score uses 1 sources.